Next Article in Journal
Phytochemical Profile, Antioxidant Activity, and Cytotoxicity Assessment of Tagetes erecta L. Flowers
Previous Article in Journal
A Tuneable, Photocurable, Poly(Caprolactone)-Based Resin for Tissue Engineering—Synthesis, Characterisation and Use in Stereolithography
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

New Adenosine Derivatives from Aizoon canariense L.: In Vitro Anticholinesterase, Antimicrobial, and Cytotoxic Evaluation of Its Extracts

1
Department of Pharmacognosy, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), Giza 11787, Egypt
2
Department of Organic and Medicinal Chemistry, Faculty of Pharmacy, University of Sadat City, Sadat 32897, Egypt
3
Department of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt
4
Center for Drug Discovery Research and Development, Ain Shams University, Cairo 11566, Egypt
5
Department of Biochemistry, Faculty of Pharmacy, University of Sadat City, Sadat 32897, Egypt
6
Department of Pharmacognosy, Faculty of Pharmacy, University of Sadat City, Sadat 32897, Egypt
*
Author to whom correspondence should be addressed.
Molecules 2021, 26(5), 1198; https://doi.org/10.3390/molecules26051198
Submission received: 22 January 2021 / Revised: 19 February 2021 / Accepted: 20 February 2021 / Published: 24 February 2021

Abstract

:
Aizoaceae is a large succulent family characterized by many psychoactive species. Aizoon canariense L., a wild neglected plant traditionally used in gastrointestinal ailments, has been the subject of a limited number of phytochemical and biological studies. Therefore, herein, we investigated the in vitro cytotoxic, antimicrobial, and anticholinesteraseactivity of the aerial parts of A. canariense L. and analyzed the phytochemical compositions of the lipoidal and alkaloidal fractions. Petroleum ether extract showed the presence of behenic and tricosylic acid, while an in-depth investigation of the alkaloidal fraction revealed the identification of new adenine based alkaloids (1–5), which were isolated and identified for the first time from Aizoon canariense L. Their structures were elucidated based on extensive spectroscopic analyses. The alkaloidal extract showed a powerful cytotoxic effect (IC50 14–28 μg/mL), with the best effect against colon carcinoma, followed by liver and breast carcinomas. The alkaloidal extract also had a potent effect against Candida albicans and Escherichia coli, with minimum inhibitory concentrations (MIC) values of 312.5 and 625 µg/mL. The in vitro anticholinesterase activity was potent, with IC50 < 200 ng/mL for the tested extracts compared with 27.29 ± 0.49 ng/mL for tacrine.

1. Introduction

African plants have been proven to have encouraging healing powers but are scarce in scientific investigations. Many studies have shown promising antimicrobial, cytotoxic, and enzyme inhibitory effects, correlated with the diversity of their phytoconstituents [1,2]
Aizoaceae, the “ice plant”, is the largest family of succulent leaves, consisting of 135 genera and 2499 species. Aizoaceae is characterized by its flavonoids, as reported in Aptenia [3,4] and Trianthema [5,6], and alkaloids, as identified in Sceletium species [7], in addition to sterols and triterpenes [8]. Alkaloids of the family Aizoaceae are characterized by their phenolic alkaloid nature [7,9]. Six genera and ten species are recognized from Aizoaceae in Egypt, however are poorly studied [10]. Aizoon is one of the wildly grown genera of the subfamily Aizooideae [11]. Aizoon canariense L. (Gafna or Shafna) was traditionally used to treat gastrointestinal problems and as a hypotensive [12]. Limited studies have dealt with its chemical profile, demonstrating the presence of simple phenolics besides flavonoids such as quercetin [13], fatty acids such as lauric acid, and stearidonic acid, as well as omega 3 [14]. A recent study allowed the identification of flavonoid glycosides, sterols, and adenosine [15]. A. canariense L. was also reported to have moderate antioxidant and antibacterial activities [12,16], in addition to cytotoxic activity, against liver carcinoma [15].
Cancer is the second leading cause of death worldwide, causing around 9.6 million deaths in 2018. Although a huge number of research studies have investigated new drugs and treatment regimens, this number continues to increase, with 300,000 new cases diagnosed annually [17]. Plants can still apply their magic through a range of natural products, with alkaloids representing a very promising class, with antiproliferative and anti-angiogenic effects [18]. Researchers have also given attention to infectious diseases, being one of the top ten causes of death globally, mainly due to antimicrobial resistance and the decline in the number of new antibiotics being discovered. The interest in natural products as anti-infective agents dates back to before the discovery of penicillin by Alexander Fleming, from the usage of molds and herbs to treat infections [19,20]. Alkaloids are major weapons in this war [21].
Besides these activities, alkaloids have been reported to have beneficial effects in reducing the deteriorative effects of Alzheimer’s, acting with an anticholinesterase-like activity through their different classes [22]. In this study, different extracts of A. canariense L. were investigated for their biological activities, including cytotoxic, antimicrobial, anticholinesterase-related activities, whereby the alkaloidal fraction was the target for the isolation and identification of constituents using 1D and 2D NMR spectral techniques. We also report the isolation of adenine-based alkaloids for the first time in A. canariense L.

2. Results and Discussion

2.1. Chemical Characterization

Purine bases and nucleosides are produced by the turnover of nucleotides and nucleic acids, as well as from some cellular metabolic pathways [23]. Purine base is not limited to the xanthine alkaloids but it encompasses adenine and guanine glycosides [24]. Combined information from 1D and 2D NMR (COSY, and HSQC) experiments were utilized to predict the structures of compounds 15 (Figure 1, Figures S2–S16). The 1D 1H-NMR spectra of compound 2 showed the presence of 3 protons corresponding to H-2, H-8, and NH protons at δH 8.76, 8.58, and 5.67 ppm, respectively, characteristic of alkaloids with an adenine nucleus [25]. A set of 4 aromatic protons was detected at δH 7.23–7.42 ppm corresponding to H-2′′, 3′′, 5′′, and 6′′. H-1′′′ was noticed as a singlet at δH 3.65 ppm, while H-5′′′–8′′′ were observed as a broad signal corresponding to 8Hs at δH 1.29 ppm. H9′′′ was observed at δH 1.21–1.23 ppm as doublet signal counting for 3Hs. H-2′′′ and 4′′′ were displayed as two singlet signals at δH 2.88 and 2.11 ppm, respectively, and directly after the broad signal corresponding to acetate methyl groups of ribose at δH 2.05 ppm and counting for 9Hs. Ribose protons were observed at δ 3.0–3.6 ppm. The later values were in agreement with the reported data by Ciuffreda et al. for adenine nucleoside acetates [25]. The signals arising due to anomeric protons are usually reported to appear in the range of 4.0–5.9 ppm, while the protons of α-glycosides typically resonate 0.3–0.5 ppm downfield from those of the corresponding β-glycosides [26]. In compound 2, the anomeric H1′ appeared as a doublet signal at δH 4.03–4.05 ppm (J = 8.0 Hz), which is in the range of β-glycosides. Additionally, the coupling constant between H-1′ and H-2′ is 8.0 Hz. Ciuffreda et al. introduced further confirmation of anomeric configuration via the evaluation of differences between δ-values of H-2 and H-1′. The magnitude of these differences is larger than 2.15 ppm in β-derivatives and smaller than 1.85 ppm in the α-ones [25]. In our case, the difference between δ-values of the H-2 and H-1′ was 4.72, which is more than 2.15, so it should be a β-anomer.
The 1D APT 13C-NMR of compound 2 demonstrated the sugar moiety methines at δc 70–83 ppm and were phased negatively, while C-2′′′, 4′′′, and 1′′′ methylenes were reported at δc 50.52, 52.38, and 59.62 ppm, respectively, and were phased positively. Further methylenes (C-5′′′–9′′′) were reported at δc 25–32 ppm. The methyl at C-10′′′ was observed at δc 20.82 ppm and further methyls of acetates were detected at δc 25.39 and 31.69 ppm and were phased negatively. The C-3′′′ carbonyl was noticed at δc 206 ppm and was phased positively, while acetate carbonyls were observed in HSQC (Figure S5). Ester carbonyls appeared at δc 174–177 and showed coupling with both sugar and methyl Hs (Table 1). Additionally, the coupling of sugar Cs and Hs of adjacent carbons was spotted in HSQC. The characteristic coupling of ketone carbonyl C-3′′′, H-4′′′, and H-2′′′ was noticed in HSQC (207.51, 2.11 and 207.29, 2.88 ppm, respectively). In the HSQC, 6 couplings in the aromatic region were noticed that corresponded to H-2, 8, 2′′, 3′′, 5′′, and 6′′. A characteristic coupling between C-2′′′ and H-2′′′ was observed at δH 2.88, 50.45 ppm. Additionally, couplings of ribose carbons and protons were noticed. The positive MS spectrum revealed an [M]+ peak at m/z 625, suggesting a molecular formula of C31H39N5O9; therefore, compound 2 was identified as N-(4′′-((3′′′-oxononyl)oxy)phenyl)-β-adenosine-2′,3′,5′-triacetate, isolated for the first time from aerial parts of A. canariense L.
An additional adenine derivative was characterized (compound 3), where signals of H-2, H-8, and NH protons were detected at δH 8.50, 8.42, and 7.8 ppm, respectively. Compound 3—in contrast to compound 2—showed no additional aromatic protons, however methine protons of acetylated ribose were observed, as follows: H1′ at δH 4.56–4.59 ppm as a triplet signal J = 10.68 Hz (β-anomer) and H2′-H5′ at δH 3.48–3.51 ppm, while acetate methyls of ribose were noticed at δH 2.48–2.59 ppm. Surprisingly, compound 3 was recognized as a disaccharide nucleoside [27]. The second sugar moiety was identified as fully methylated rhamnopyranoside. Even though the methylated rhamnopyranoside is not common in nature, it has been previously reported by Sone et al. [28]. The chemical shifts of the methylated rhamnopyranoside moiety of compound 3 were in the same range as that previously reported by Sone et al. Thus, 3′′, 4′′, and 5′′-OCH3 were detected at δH 3.48–3.51 ppm as a singlet signal for 9Hs. Additionally, rhamnopyranose methine proton H1′′ appeared at δH 4.56–4.59 (t, J = 5.12 Hz, α-anomer), while H2′′–H5′′ were noticed at δH 3.41–3.51 ppm. The methyl group at C-6′′ was detected at δH 1.23 ppm. The alkyl side chain protons were detected at δH 1.21–1.24 (H3′′′–H8′′′), 1.72–1.73 (H2′′′ and H9′′′) ppm, and 0.84 ppm (H10′′′ and 11′′′) (Figures S7–S10). 13C-NMR of compound 3 demonstrated the sugar moieties methines at δc 60–73 ppm. Methyls of acetates were detected at δc 20.29 and 21.56, while acetate carbonyls were detected at δc 177 ppm. Methyls at C10′′′ and C11′′′ were noticed at δc 14.37 ppm, Rhamnopyranose methyl 6′′ was detected at δc 17.87 ppm and 3′′, 4′′ and 5′′-OCH3 were detected at δc 70 ppm. C1′′′ methylene was reported at δc 66 ppm, while C2′′′-9′′′ methylenes were detected at δc 20–30 ppm. In HSQC, the signal at δH 0.84 was linked to δc 14.37 ppm (terminal alkyl methyls at C10′′′ and C11′′′). Rhamnopyranose methyl 6′′ was detected at δH 1.23 and was related to δc 17.87 ppm. Several couplings corresponding to the alkyl side chain methylenes were detectable at δH 1.21, 1.24, 1.72, and 1.73 and correlated to δc 25–30 ppm. Further couplings of sugar methines and rhamnopyranose methoxy groups were observed at δH 3.41–3.51 and δc 60–75 ppm. Characteristic couplings of anomeric atoms were picked out at δH 4.5–4.6 and δc 70 ppm. The positive high-resolution electrospray ionization mass spectrometry (HR-ESI-MS) spectrum (Figure S1) revealed an [M + H]+ peak at m/z 694.6000, suggesting a molecular formula of C34H55N5O10, which was as identified as N-(9′′′-methyldecyl)-β-adenosine-2′,3′-diacetate-2′′,3′′,4′′-tri-O-methyl-α-rhamnopyranoside.
Compound 4 was recognized as the non-acetylated guanosine nucleoside analogue of compound 3. Thus, only one proton was detectable in the aromatic region at δH 7.70 ppm that corresponds to H-8, while no signals corresponding to H-2 were detectable. Additionally, NH2 protons were detectable at δH 5.32 ppm. H1′ of ribose was demonstrated at δH 4.11–4.14 ppm as a triplet signal J = 9.88 Hz (β-anomer). Further ribose protons were noticed at δH 3.34–3.57 ppm. Similar shifts of methylated rhamnopyranoside in compound 3 were demonstrated. Thus, H1′′′ detected at δH 4.11–4.14 ppm (t, 3.8 Hz, α-anomer) and H2′′-H5′′ was elucidated at δH 3.34–3.57 ppm, while H6′′ at δH 1.23 ppm and 3′′, 4′′, 5′′-OCH3 was detected at δH 3.51 ppm as a singlet signal for 9Hs. The alkyl side chain was formed of 13 carbons. H3′′′–H11′′′ were detected at δH 1.21–1.24 ppm, H2′′′ at δ 2.00 ppm, while H1′′′ appeared at δH 3.34–3.45 ppm and H12′′′–H13′′′ at δH 0.85 ppm (Figures S11–S13). 13C-NMR of compound 4 revealed the sugar moiety methines at δc 60–73 ppm. Methyls at C12′′′ and C13′′′ were noticed at δc 11 ppm, rhamnopyranose methyl 6′′ at δc 14 ppm, and 3′′–5′′-OCH3 at δc 70 ppm. C1′′′ methylene was observed at δc 67 ppm, while C2′′′–11′′′ methylenes were noticed at δc 22–33 ppm. The HSQC showed the correlation between H at δH 0.85 ppm and C at δc 11.0 and 14.0 ppm. Additionally, Hs at δH 1.21–1.24 ppm correlated with Cs at δc 22–33 ppm. Protons at δH 1.23 and 2.0 ppm were related to C at δc 25 and 27 ppm, respectively. Couplings of Hs at δH 3.34–3.57 ppm were discerned with carbons in the range of δc 60–75 ppm. The anomeric protons at δH 4.11–4.14 ppm were coupled with Cs at δc 65 and 70 ppm. The positive HR-ESI-MS spectrum (Figure S1) revealed an [M + H]+ peak at m/z 654.7000, suggesting a molecular formula of C32H55N5O9 identified as O-(11′′′-methyldodecyl)-β-guanosine-2′′,3′′,4′′-tri-O-methyl-α-rhamnopyranoside.
For compound 5, the positive MS spectrum revealed an [M + H]+ peak at m/z 394, while the negative MS spectrum revealed an [M − H] peak at m/z 392, suggesting a molecular formula of C20H35N5O3 (Figure S1). Moreover, 1D 1H-NMR spectra showed typical adenine signals of H-2, H-8, and NH protons at δH 8.50, 7.97, and 5.44 ppm respectively. Neither aromatic nor sugar protons were detectable. Protons of methyl groups (H-11′′′ and 12′′′) were noticed as multiplet signal at δH 0.83–0.89 ppm. H-10′′′ was detected at δH 1.84 ppm while H2′′′-6′′′, 8′′′ and 9′′′ were noticed at δH 1.16–1.28 ppm and corresponding to 14Hs. H-14′′′ and 15′′′ were identified downfield as doublet signal at δH 2.35–2.37 ppm counting for 4 Hs. The most deshielded protons were spotted at δH 2.47 ppm (H-7′′′ and 13′′′) and 3.17 ppm (H-1′′′). In HSQC, H at δH 8.50 was correlated to C at 143.07, multiple signals at δH 0.83–0.89 ppm was connected to Cs at δc 12.24, 15.64, 22.27, and 23.25 ppm. Protons at δH 1.16–1.28 ppm were coupled with Cs at δc 21.14–31.18 ppm. Signals at δH 1.84, 2.35–2.37, and 2.47 ppm were associated with Cs at δc 22.76, 30.53, and 21.30 ppm respectively (Figures S14–S16). Compound 5 was identified as 2-((11-(6-amino-9H-purin-9-yl)-2-methylundecan-5-yl)oxy)propane-1,3-diol.
Compound 1 was also recognized as a purine derivative. The characteristic two protons of purine in the aromatic region corresponding to H8 and H2 were detected at δH 7.67–7.73 ppm. Signals of monoacetylated ribose, methylated rhamnopyranoside, and the alkyl side chain were noticeable in the same range as in compounds B, C, and D, as per Table 1 and Figure S2. Anomeric H1′ and H1′′ in sugar moieties were demonstrated at δH 4.13–4.15 ppm (q, 3.52, 5.56 Hz, α-anomers). The positive HR-ESI-MS spectrum (Figure S1) revealed an [M + H]+ peak at m/z 679.5000, suggesting a molecular formula of C35H58N4O9. The correlation of H and C of acetylated ribose; methylated rhamnopyranoside; and the aliphatic side chain of compounds 2, 3, 4, and 5 were demonstrated by HSQC, as per Figures S2–S16. Compound 1 was identified as 6-(12′′′-methyltridecyl)-9H-purin-9-yl-3′-monoacetate-α-ribofuranoyl-2′′,3′′,4′′-tri-O-methyl-α-rhamnopyranoside.

2.2. Determination of the Lipoidal Matter

Fatty acids have a vital role in maintaining the structural integrity of cellular membranes, as well as being a great energy source and being present in signaling molecules Studies showed that Alzheimer’s disease patients have reduced levels of polyunsaturated and monounsaturated fatty acids [29,30], therefore supplementation of such fatty acids may ameliorate cognitive functions. GLC analysis of A. canariense L. petroleum ether extract allowed the identification of 91.7% of its fatty acid content, characterized by being long (C14–C22) and very long-chain fatty acids (more than 22 carbons) (Table 2). Saturated fatty acids showed their predominance, with tricosanoic acid (C23) being the major identified saturated fatty acid (43%), followed by behenic acid (C22), which has a role in skincare as an emollient and is able to restore the skin’s natural oils and improve overall levels of hydration [31]. Nervonic acid (C-24:1 Δ15, cis-15-tetracosenoic acid) is the major unsaturated fatty acid. It is a monounsaturated analog of lignoceric acid, which is known to enhance brain function and prevent demyelination. Additionally, it was proven to ameliorate memory function and to improve the activity of γ-glutamate cysteine ligase in the cerebral cortex [32,33]. Eicosenoic acid (C-20), also called gondoic acid, is a monounsaturated omega 9 fatty acid, which was reported to cause a mild reduction in NO levels and to reduce LPS-induced increase in iNOS, therefore having a mild anti-inflammatory effect [34].

2.3. Biological Activities

2.3.1. In Vitro Cytotoxic Activity

The different A. canariense L. extracts were screened for their cytotoxic, antimicrobial, and acetylcholinesterase inhibitory activities (Table 3). Cytotoxic activity was evaluated for alkaloidal as well as methanolic extracts of A. canariense L., against three cancer cell lines, namely breast carcinoma (MCF-7), hepatocellular carcinoma (HepG-2), and colon carcinoma (HCT-116), using sample concentrations ranging from 0 to 500 μg/mL. The results of the cytotoxic activity of A. canariense L. extracts revealed that the alkaloidal extract had the most powerful effect (IC50 14–28 μg/mL), with the best effect against HCT-116, followed by HepG-2 then MCF-7. The methanolic extract showed comparable results with higher IC50 (Table 3). The powerful cytotoxic potential of A. canariense L. was previously demonstrated against human CCRF-CEM leukemia cells [35] and HepG2 [15].

2.3.2. Antimicrobial Activity

The antimicrobial activity levels of both methanolic and alkaloidal extracts were evaluated using the disc diffusion method against Gram-positive, Gram-negative, and fungi compared with reference antimicrobial and antifungal agents. MIC values were estimated for the most sensitive micro-organisms (Table 4 and Table 5). Through this study, the alkaloidal extract showed high activity against Candida albicans and Salmonella typhimurium and moderate activity against Bacillus subtilis, while the methanolic extract showed promising antifungal activity against Aspergillus flavus, which was comparable to ketoconazole, as well as moderate activity against Staphylococcus aureus and Escherichia coli. Comparing the MIC values of the alkaloidal and the methanolic extracts of A. canariense L., the alkaloidal extract had better activity against Candida albicans and Escherichia coli, with MIC values of 312.5 and 625 µg/mL, respectively, while the methanolic extract showed better activity against Staphylococcus aureus and Bacillus subtilis, with MIC values of 625 µg/mL for both. The potent antifungal effect was supported by a previous report demonstrating a powerful effect against A. fumigatus [16].

2.3.3. Anticholinesterase Activity

The increase in acetylcholinesterase (AChE) activity is the most characteristic change that occurs in Alzheimer’s disease. AChE is the enzyme responsible for acetylcholine hydrolysis, from both cholinergic and non-cholinergic neurons of the brain. The increase in acetylcholine level can be achieved by inhibition of AChE, which helps in the treatment of Alzheimer’s disease. The inhibitory activity of acetylcholinesterase was assessed using BioAssay Systems’ QuantiChromTM Screening kit based on an improved Ellman method. Through this work, the anti-Alzheimer’s activities (AChE enzyme inhibition activity) of the crude methanolic, dichloromethane, alkaloidal, as well as aqueous alkaloidal extracts of A. canariense L. were evaluated in vitro and compared with that of the standard tacrine (AChE inhibitor). The results are shown in Table 3 and Figure 2, representing the % inhibition levels at 10–1000 µg/mL and IC50 for the different extracts. The results demonstrated that the methanolic extract showed significant activity with IC50 = 112.24 ± 7.73 ng/mL, along with the aqueous alkaloid extract with IC50 =139.27 ± 21.40 ng/mL. Moreover, the dichloromethane extract showed the highest (very potent) and most promising anti-acetylcholinesterase activity with IC50 = 62.48 ± 1.31 ng/mL compared to the standard drug (AChE inhibitor) tacrine, with IC50 = 27.29 ± 0.49 ng/mL (Table 3). Taken together, these results demonstrated a considerable anti-Alzheimer’s activity of the extract. The ability of Aizoaceae plants to manage Alzheimer’s was previously demonstrated with Trianthema portulacastrum, mainly in the phenolic-rich fraction, where docking studies confirmed the significant binding affinity of chlorogenic acid towards AChE [36], while an in vivo model using Sceletium tortuosum showed cognitive set flexibility and executive function and positive changes in mood and sleep compared with the placebo group [37].

3. Experimental

3.1. Plant Material

Fresh whole-plant samples of Aizoon canariense L. (F. Aizoaceae) were collected from Cairo-Ismailia Road in February 2017 and kindly identified by Prof. Dr. A.A. Fayed, Professor of Plant Taxonomy, Faculty of Science, Assiut University, Assiut, Egypt. A voucher specimen is placed at the Herbarium of the Faculty of Science, Assiut University, Assiut, Egypt.

3.2. General Experimental Procedures

NMR analyses (1H, 13C, COSY, and HSQC) were performed on a Bruker instrument (Billerica, MA, USA; 400 and 100 MHz for 1H- and 13C-NMR, respectively) using DMSO-d6 as a solvent and with chemical shift values given in δ (ppm) and referenced to the TMS signal as an internal reference. All samples were prepared in suitable deuterated solvents. An ultra-mass spectrometer was used (Thermo FisherScientific, Bremen, Germany), equipped with a Nanomate electrospray ionization (ESI) interface (Advion). An electrospray voltage of 1.7 kV (+/−) and a transfer capillary temperature of 200 °C were applied. Chromatographic analysis was carried out on TLC plates (Merck, Germany) using CH2Cl2–MeOH at different ratios, while column chromatographic separation was performed using a silica gel column with CH2Cl2 and gradient increase of MeOH. The analysis of fatty acid methyl esters was performed on an Agilent 19091J-413 gas chromatography instrument equipped with a flame ionization detector (FID), for which an HP-5 5% phenyl methyl siloxane capillary column (30 m × 320 µm × 0.25 µm) was used. The injector temperature was 250 °C, with an average velocity of 27 cm/s. H2 was the carrier gas, with a flow rate of 30 mL/min. The detector operated at a temperature of 280 °C.

3.3. Extraction and Isolation

The dried and powdered plant material (0.5 kg) was defatted with petroleum ether until exhaustion, then plant material was exhaustively extracted with 95% methanol. Acid–base extraction was applied as previously reported [38], allowing the separation of the polar aqueous fraction (7 g) from the non-polar alkaloidal fraction (2 g), both giving a positive reaction with Dragendorff’s. The aqueous alkaloidal fraction (7 g) was chromatographed on a silica gel column (150 g, 100 × 3 cm) using a gradient elution of the CH2Cl2/MeOH mixture as a mobile phase. Then, 100 fractions were collected and similar fractions depending on TLC monitoring and visualization using Dragendorff’s reagent were gathered and concentrated, resulting in four main fractions. Fraction 1 (1–20) eluted with CH2Cl2: MeOH (90:10) was neglected, as it consisted of traces of many compounds. Fraction 2 CH2Cl2: MeOH (80:20) consisted of a mixture of 2 major spots, with some other impurities. Therefore, it was separated and purified using preparative high-performance liquid chromatography (HPLC) equipped with an RP-C18 column (Kromasil®, Bohus, Sweden; 5 µm, 250 mm × 10 mm), using a mobile phase consisting of 0.1% trifluroacetic acid in water (A)–MeOH (B) (HPLC grade) in the following sequence: 95% in 2 min, 95% to 50% in 23 min, 50% to 30% in 5 min. A photodiode array detector (Knauer K-2501, Berlin, Germany) was used. Samples were injected using a 100 µL glass syringe (VIGI syringe, USA; Knaur® injector, D-14163, Berlin, Germany) yielding compounds 1 and 2 (10 and 20 mg, respectively). Fraction 3 (CH2Cl2: MeOH (70:30)) was further purified on another silica gel sub-column (60 g, 60 × 2 cm) using a gradient elution of the CH2Cl2–MeOH mixture as a mobile phase to yield compounds 3 (15 mg), 4 (20 mg), and 5 (10 mg).

3.4. Determination of Lipoidal Matter

Here, 1 g of petroleum ether extract was refluxed with KOH for three hours, then the mixture was partitioned with diethyl ether. The aqueous layer was acidified with HCl, extracted with diethyl ether, and then the ethereal extract was esterified by refluxing with H2SO4–MeOH at a ratio of 3:50 for three hours. The ethereal layer was then collected and the residue was kept for GLC analysis. The identification of the fatty acid methyl esters was carried out by comparing retention times with the applied authentic sample. The quantitative estimation of each peak was achieved by using a computer integrator, adopting the internal normalization procedures [39].

3.5. Cell Culture

All cell lines used in this study were obtained from Nawah Scientific, Inc. (Mokatam, Cairo, Egypt). Cells were maintained in DMEM media supplemented with 100 mg/mL of streptomycin, 100 units/mL of penicillin, and 10% heat-inactivated fetal bovine serum in a humidified 5% (v/v) CO2 atmosphere at 37 °C.

3.6. Screening of Cytotoxic Activity

The cytotoxic activity of both methanolic and alkaloidal extracts was estimated using 3-(4,5-dimethylthiazol-2-yl)-2–5-diphenyltetrazolium bromide (MTT) assay against human breast cancer (MCF-7), liver cancer (HEPG2), and colon cancer (HCT-116) cell lines [40,41]. Principally, the MTT assay measures cell viability through the determination of the mitochondrial function of cells by measuring the activity of various mitochondrial enzymes (Stone V). Cell viability was determined using a cell proliferation kit [40] according to the manufacture’s protocol, while the optical density was measured at 590 nm with the microplate reader (SunRise, TECAN, Inc, Mannedorf, Switzerland) to determine the number of viable cells and the percentage of viability was calculated as (1 − (ODt/ODc)] × 100%), where ODt is the mean optical density of wells treated with the tested sample and ODc is the mean optical density of untreated cells. The relationships between surviving cells and drug concentrations were plotted to get the survival curve of each tumor cell line after treatment with the specified compound. The 50% inhibitory concentration (IC50), the concentration required to cause toxic effects in 50% of intact cells, was estimated from graphic plots of the dose–response curve for each concentration using GraphPad Prism v.8.4.2. (San Diego, CA, USA), as indicated. Here, p values < 0.05 were considered statistically significant.

3.7. Determination of Antimicrobial Activity

The minimum inhibitory concentration (MIC) values were determined for the different A. canariense L. extracts using the broth microdilution method against Gram-positive (Staphylococcus aureus (RCMB 010010), Bacillus subtilis (RCMB 015, NRRL B-543)) and Gram-negative bacteria (Salmonella typhimurium (RCMB 006, ATCC 14028), Escherichia coli (RCMB 010052, ATCC25955), in addition to fungi (Aspergillus flavus (RCMB 002002), Candida albicans (RCMB 005003, ATCC )), using 96-well microplates at the Regional Centre for Mycology and Biotechnology (RCMB) at AL-Azhar University, Nasr City, Egypt [42]. Microbial growth was indicated by the turbidity of the well. The lowest concentration showing no growth was taken as the minimum inhibitory concentration [43].

3.8. Anticholinesterase Activity

The most important enzyme controlling acetylcholine (ACh) levels in healthy brains is acetylcholinesterase (AChE), while butyrylcholinesterase (BChE) is involved to a lesser extent [44]. The anticholinesterase activity levels of the different A. canariense L. extracts were estimated using a QuantiChromTM kit, IACE-100, (BioAssay Systems, Hayward, CA, USA). The acetylcholinesterase inhibitor screening kit is dependent on an enzyme-catalyzed kinetic reaction [45]. The enzyme source, according to the manufacturer’s instructions, is E. electricus. The enzyme hydrolyzes the substrate acetylthiocholine, resulting in the production of thiocholine, which reacts with 5,5’-dithio-bis (2-nitrobenzoic acid) (DTNB) to form 2-nitrobenzoate-5-mercaptothiocholine and 5-thio-2-nitrobenzoate, which can be detected at 412 nm [46,47]. Briefly, and according to the manufacturer’s instructions, 45 μL samples of AChE (400 U/L) were incubated with 5 μL samples of tested extracts at a series of concentrations ranging from 1 to 500 μg/mL or 5 μL of 40 v% DMSO in a 96-well microplate. While in a separate well, 45 μL of assay buffer was used instead of AChE to achieve 100% inhibition in the negative control. The reaction mixture was incubated for 15 min at 37 °C. For each well, 150 μL of assay buffer was added, containing 1 μL substrate and 0.5 μL DTNB. The thiocholine produced by the action of acetylcholinesterase forms a yellow color with DTNB. The intensity of the produced color measured at 412 nm is proportionate to the enzyme activity in the sample. The optical density of the tested extracts was measured at 412 nm at 0 and 10 min in a plate reader compared with tacrine (Santa Cruz Biotechnology Cat# sc-200172) as standard (AChE inhibitor). The anticholinesterase activity was calculated as follows: % inhibition = 1 − (ΔOD test/ΔOD control) ×100 [48].

3.9. Statistical Analysis

Statistical analysis of the data was performed using one-way ANOVA, followed by Tukey’s multiple range test for post-hoc comparisons (GraphPad Prism, version 8.4.2). All the data are presented as the means of 3 determinations ± SE. The p value significance levels are represented as asterisks (*) for p < 0.05, (**) p < 0.01, and (***) p < 0.001.

4. Conclusions

This study provides the first report for the isolation and characterization of five adenine-based alkaloids from the polar alkaloidal fraction after acid–base extraction of the aerial parts of A. canariense L. The alkaloidal fraction of A. canariense L. showed a promising cytotoxic effect against HCT-116, MCF-7, and, HepG-2, in addition to significant antimicrobial effects. Furthermore, the alkaloid fraction, as well as dichloromethane (flavonoid containing fraction), showed a significant effect against Alzheimer’s disease, which requires further in vivo studies. The predominance of behenic and tricosanoic acids in the non-polar fraction, as well as the adenine-based alkaloids, may correlate to the potential effects in cerebral disorders. Our work revealed A. canariense L. a potential candidate for the treatment of many ailments.

Supplementary Materials

The following are available online. Figure S1: Mass spectra of compounds 1, 2, 3, 4, 5 positive mode and 5 negative mode; Figure S2: 1H-NMR of compound 1; Figure S3: 1H-NMR of compound 2; Figure S4: 1D APT 13CNMR of compound 2; Figure S5: HSQC of compound 2; Figure S6: COSY of compound 2; Figure S7: 1H-NMR of compound 3; Figure S8: 13C-NMR of compound 3; Figure S9: HSQC of compound 3; Figure S10: magnified HSQC of compound 3; Figure S11: 1H-NMR of compound 4; Figure S12: 13C-NMR of compound 4; Figure S13: HSQC of compound 4; Figure S14: 1H-NMR of compound 5; Figure S15: HSQC of compound 5.

Author Contributions

R.O.B., M.A.A.F., conceptualization, data curation, methodology, writing—reviewing and editing. H.E., A.M.E., M.F.E.-B., investigation, methodology, data curation, writing—reviewing and editing manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not available.

Conflicts of Interest

There are no conflict to declare.

References

  1. Bibi Sadeer, N.; Llorent-Martínez, E.J.; Bene, K.; Fawzi Mahomoodally, M.; Mollica, A.; Ibrahime Sinan, K.; Stefanucci, A.; Ruiz-Riaguas, A.; Fernández-de Córdova, M.L.; Zengin, G. Chemical profiling, antioxidant, enzyme inhibitory and molecular modelling studies on the leaves and stem bark extracts of three African medicinal plants. J. Pharm. Biomed. Anal. 2019, 174, 19–33. [Google Scholar] [CrossRef] [PubMed]
  2. Mahomoodally, M.F.; Picot-Allain, C.; Hosenally, M.; Ugurlu, A.; Mollica, A.; Stefanucci, A.; Llorent-Martínez, E.J.; Baloglu, M.C.; Zengin, G. Multi-targeted potential of Pittosporum senacia Putt.: HPLC-ESI-MSn analysis, in silico docking, DNA protection, antimicrobial, enzyme inhibition, anti-cancer and apoptotic activity. Comput. Biol. Chem. 2019, 83, 107114. [Google Scholar] [CrossRef]
  3. Elgindi, M.R.; Elgindi, O.; Mabry, T. Flavonoids of Aptenia cordifolia. Asian J. Chem. 1999, 11, 1525–1527. [Google Scholar]
  4. DellaGreca, M.; Di Marino, C.; Previtera, L.; Purcaro, R.; Zarrelli, A. Apteniols A-F, oxyneolignans from the leaves of Aptenia cordifolia. Tetrahedron 2005, 61, 11924–11929. [Google Scholar] [CrossRef]
  5. Kokpol, U.; Wannachet-isara, N.; Tip-pyang, S.; Chavasiri, W.; Veerachato, G.; Simpson, J.; Weavers, R.T. A c-methylflavone from Trianthema portulacastrum. Phytochemistry 1997, 44, 719–722. [Google Scholar] [CrossRef]
  6. Sarker, S.D.; Šik, V.; Dinan, L. Isoamericanin A: A neolignan from Trianthema turgidifolia. Biochem. Syst. Ecol. 1998, 26, 681–683. [Google Scholar] [CrossRef]
  7. Gericke, N.; Viljoen, A.M. Sceletium—A review update. J. Ethnopharmacol. 2008, 119, 653–663. [Google Scholar] [CrossRef]
  8. Patterson, G.W.; Xu, S. Sterol composition in five families of the order Caryophyllales. Phytochemistry 1990, 29, 3539–3541. [Google Scholar] [CrossRef]
  9. Jeffs, P.W.; Capps, T.M.; Redfearn, R. Sceletium Alkaloids. Structures of Five New Bases from Sceletium namaquense. J. Org. Chem. 1982, 47, 3611–3617. [Google Scholar] [CrossRef]
  10. Boulos, L. Flora of Egypt: Checklist; Al Hadara Pub: Cairo, Egypt, 2009; ISBN 9789774760020. [Google Scholar]
  11. Klak, C.; Hanáček, P.; Bruyns, P.V. Out of southern Africa: Origin, biogeography and age of the Aizooideae (Aizoaceae). Mol. Phylogenet. Evol. 2017, 109, 203–216. [Google Scholar] [CrossRef]
  12. Al-Laith, A.A.; Alkhuzai, J.; Freije, A. Assessment of antioxidant activities of three wild medicinal plants from Bahrain. Arab. J. Chem. 2015. [Google Scholar] [CrossRef] [Green Version]
  13. Phoboo, S.; Shetty, K.; ElObeid, T. In vitro assays of anti-diabetic and anti- hypertensive potential of some traditional edible plants of Qatar. J. Med. Act. Plants 2015, 4, 22–29. [Google Scholar] [CrossRef]
  14. Freije, A.; Alkhuzai, J.; Al-Laith, A.A. Fatty acid composition of three medicinal plants from Bahrain: New potential sources of γ-linolenic acid and dihomo-γ-linolenic. Ind. Crops Prod. 2013, 43, 218–224. [Google Scholar] [CrossRef]
  15. Abuzaid, H.; Amin, E.; Moawad, A.; Abdelmohsen, U.R.; Hetta, M.; Mohammed, R. Liquid chromatography high-resolution mass spectrometry analysis, phytochemical and biological study of two Aizoaceae plants: A new kaempferol derivative from Trianthema portulacastrum L. Pharmacogn. Res. 2020, 12, 212. [Google Scholar] [CrossRef]
  16. El-Amier, Y.A.; Haroun, S.A.; El-Shehaby, O.A.; Al-hadithy, O.N. Antioxidant and antimicrobial properties of some wild Aizoaceae species growing in Egyptian desert. J. Environ. Sci. 2016, 45, 1–10. [Google Scholar]
  17. Ferlay, J.; Ervik, M.; Lam, M.; Colombet, M.; Mery, L.; Piñeros, M.; Znaor, A.; Soerjomataram, I.; Bray, F. Global Cancer Observatory. Available online: https://gco.iarc.fr/ (accessed on 22 September 2019).
  18. Habli, Z.; Toumieh, G.; Fatfat, M.; Rahal, O.N.; Gali-Muhtasib, H. Emerging cytotoxic alkaloids in the battle against cancer: Overview of molecular mechanisms. Molecules 2017, 22, 250. [Google Scholar] [CrossRef] [PubMed]
  19. Rahman, M.; Sarker, S.D. Antimicrobial natural products. In Annual Reports in Medicinal Chemistry; Academic Press: Cambridge, MA, USA, 2020; Volume 55, pp. 77–113. ISBN 9780128210192. [Google Scholar]
  20. Durand, G.A.; Raoult, D.; Dubourg, G. Antibiotic discovery: History, methods and perspectives. Int. J. Antimicrob. Agents 2019, 53, 371–382. [Google Scholar] [CrossRef] [PubMed]
  21. Mittal, R.P.; Jaitak, V. Plant derived natural alkaloids as new antimicrobial and adjuvant agents in existing antimicrobial therapy. Curr. Drug Targets 2019, 20. [Google Scholar] [CrossRef]
  22. Ng, Y.P.; Or, T.C.T.; Ip, N.Y. Plant alkaloids as drug leads for Alzheimer’s disease. Neurochem. Int. 2015, 89, 260–270. [Google Scholar] [CrossRef]
  23. Ashihara, H.; Stasolla, C.; Fujimura, T.; Crozier, A. Purine salvage in plants. Phytochemistry 2018, 147, 89–124. [Google Scholar] [CrossRef] [PubMed]
  24. Miao, B.J.; Chen, J.; Shao, J.H.; Xu, X.Q.; Zhao, C.C.; Wang, Y.P. A New Adenine Glycoside from the Flowers of Brassica rapa. Chem. Nat. Compd. 2018, 54, 327–329. [Google Scholar] [CrossRef]
  25. Ciuffreda, P.; Casati, S.; Manzocohi, A. Spectral assignments and reference data complete1H and 13C NMR spectral assignment of α- And β-adenosine, 2′-deoxyadenosine and their acetate derivatives. Magn. Reson. Chem. 2007, 45, 781–784. [Google Scholar] [CrossRef]
  26. Periyannan, G.R.; Lawrence, B.A.; Egan, A.E. 1H-NMR spectroscopy-based configurational analysis of mono- and disaccharides and detection of β-glucosidase activity: An undergraduate biochemistry laboratory. J. Chem. Educ. 2015, 92, 1244–1249. [Google Scholar] [CrossRef]
  27. Efimtseva, E.V.; Kulikova, I.V.; Mikhailov, S.N. Disaccharide nucleosides as an important group of natural compounds. Mol. Biol. 2009, 43, 301–312. [Google Scholar] [CrossRef]
  28. Sone, H.; Kigoshi, H.; Yamada, K. Aurisides A and B, cytotoxic macrolide glycosides from the Japanese sea hare Dolabella auricularia. J. Org. Chem. 1996, 61, 8956–8960. [Google Scholar] [CrossRef] [PubMed]
  29. Martín, V.; Fabelo, N.; Santpere, G.; Puig, B.; Marín, R.; Ferrer, I.; Díaz, M. Lipid alterations in lipid rafts from Alzheimer’s disease human brain cortex. J. Alzheimer’s Dis. 2010, 19, 489–502. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  30. Hussain, G.; Schmitt, F.; Loeffler, J.P.; de Aguilar, J.L.G. Fatting the brain: A brief of recent research. Front. Cell. Neurosci. 2013, 7, 144. [Google Scholar] [CrossRef] [Green Version]
  31. Banov, D.; Banov, F.; Bassani, A.S. Case Series: The effectiveness of fatty acids from Pracaxi oil in a topical silicone base for scar and wound therapy. Dermatol. Ther. Heidelb. 2014, 4. [Google Scholar] [CrossRef] [Green Version]
  32. Yuan, H.; Wang, Q.; Wang, Y.; Xie, C.; Xie, K.; Zhao, X. Effect of docosahexaenoic acid and nervonic acid on the damage of learning and memory abilities in rats induced by 1-bromopropane. Chin. J. Ind. Hyg. Occup. Dis. 2013, 31, 806–810. [Google Scholar]
  33. Li, Q.; Chen, J.; Yu, X.; Gao, J.M. A mini review of nervonic acid: Source, production, and biological functions. Food Chem. 2019, 301, 125286. [Google Scholar] [CrossRef]
  34. Pereira, D.M.; Correia-da-Silva, G.; Valentão, P.; Teixeira, N.; Andrade, P.B. Anti-Inflammatory effect of unsaturated fatty acids and ergosta-7,22-dien-3-ol from Marthasterias glacialis: Prevention of CHOP-Mediated ER-stress and NF-κB activation. PLoS ONE 2014, 9, e88341. [Google Scholar] [CrossRef]
  35. Adam, M.; Elhassan, G.O.M.; Yagi, S.; Senol, F.S.; Orhan, I.E.; Ahmed, A.A.; Efferth, T. In-vitro antioxidant and cytotoxic activities of 18 plants from the Erkowit region, Eastern Sudan. Nat. Prod. Bioprospect. 2018, 8, 97. [Google Scholar] [CrossRef] [Green Version]
  36. Yadav, E.; Singh, D.; Debnath, B.; Rathee, P.; Yadav, P.; Verma, A. Molecular docking and cognitive impairment attenuating effect of phenolic compound rich fraction of Trianthema portulacastrum in scopolamine induced Alzheimer’s disease like condition. Neurochem. Res. 2019, 44, 1665–1677. [Google Scholar] [CrossRef] [PubMed]
  37. Chiu, S.; Gericke, N.; Farina-Woodbury, M.; Badmaev, V.; Raheb, H.; Terpstra, K.; Antongiorgi, J.; Bureau, Y.; Cernovsky, Z.; Hou, J.; et al. Proof-of-concept randomized controlled study of cognition effects of the proprietary extract Sceletium tortuosum (Zembrin) targeting phosphodiesterase-4 in cognitively healthy subjects: Implications for Alzheimer’s dementia. Evid. Based Complement. Altern. Med. 2014, 2014, 1–9. [Google Scholar] [CrossRef]
  38. Zhang, Q.-W.; Lin, L.-G.; Ye, W.-C. Techniques for extraction and isolation of natural products: A comprehensive review. Chin. Med. 2018, 13, 20. [Google Scholar] [CrossRef] [Green Version]
  39. Paquot, C. Standard Methods for the Analysis of Oils, Fats and Derivatives; Elsevier: Amsterdam, The Netherlands; Pergamon Press: Oxford, UK, 1979. [Google Scholar]
  40. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55–63. [Google Scholar] [CrossRef]
  41. Riyadh, S.M.; Gomha, S.M.; Mahmmoud, E.A.; Elaasser, M.M. Synthesis and anticancer activities of thiazoles, 1,3-thiazines, and thiazolidine using chitosan-grafted-poly(vinylpyridine) as basic catalyst. Chem. Heterocycl. Compd. 2015, 51, 1030–1038. [Google Scholar] [CrossRef]
  42. Saini, K.R.; Choudhary, S.A.; Joshi, Y.C.; Joshi, P. Solvent free synthesis of chalcones and their antibacterial activities. E-J. Chem. 2005, 2, 224–227. [Google Scholar] [CrossRef] [Green Version]
  43. Gomha, S.M.; Abbas, I.M.; Elneairy, M.A.A.; Elaasser, M.M.; Mabrouk, B.K.A. Antimicrobial and anticancer evaluation of a novel synthetic tetracyclic system obtained by Dimroth rearrangement. J. Serbian Chem. Soc. 2015, 80, 1251–1264. [Google Scholar] [CrossRef]
  44. Ahmed, F.; Ghalib, R.; Sasikala, P.; Mueen Ahmed, K. Cholinesterase inhibitors from botanicals. Pharmacogn. Rev. 2013, 7, 121–130. [Google Scholar] [CrossRef] [Green Version]
  45. Magnotti, R.A.; Eberly, J.P.; Quarm, D.E.; McConnell, R.S. Measurement of acetylcholinesterase in erythrocytes in the field. Clin. Chem. 1987, 33, 1731–1735. [Google Scholar] [CrossRef] [PubMed]
  46. Ellman, G.L.; Courtney, K.D.; Andres, V.; Featherstone, R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7. [Google Scholar] [CrossRef]
  47. Refaey, M.S.; Abdelhamid, R.A.; Elimam, H.; Elshaier, Y.A.M.M.; Ali, A.A.; Orabi, M.A.A. Bioactive constituents from Thunbergia erecta as potential anticholinesterase and anti-ageing agents: Experimental and in silico studies. Bioorg. Chem. 2021, 108, 104643. [Google Scholar] [CrossRef] [PubMed]
  48. Dhanasekaran, S.; Perumal, P.; Palayan, M. In-vitro Screening for acetylcholinesterase enzyme inhibition potential and antioxidant activity of extracts of Ipomoea aquatica Forsk: Therapeutic lead for Alzheimer’s disease. J. Appl. Pharm. Sci. 2015, 5, 12–16. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Structures of compounds 15 isolated from aerial parts of A. canariense L.
Figure 1. Structures of compounds 15 isolated from aerial parts of A. canariense L.
Molecules 26 01198 g001
Figure 2. Percentage inhibition of the different A. canariense L. extracts. Note: *** p < 0.001 significant values compared to tacrine 1000 µg/mL; ### p < 0.001 significant values compared to tacrine 100 µg/mL; +++ p < 0.001 significant values compared to tacrine 10 µg/mL.
Figure 2. Percentage inhibition of the different A. canariense L. extracts. Note: *** p < 0.001 significant values compared to tacrine 1000 µg/mL; ### p < 0.001 significant values compared to tacrine 100 µg/mL; +++ p < 0.001 significant values compared to tacrine 10 µg/mL.
Molecules 26 01198 g002
Table 1. 1H- and 13C-NMR data for compounds 15 (DMSO-d6).
Table 1. 1H- and 13C-NMR data for compounds 15 (DMSO-d6).
Compound No.Compound 1Compound 2Compound 3Compound 4Compound 5
PositionδH [m, J (Hz)]δH [m, J (Hz)]δCδH [m, J (Hz)]δCδH [m, J (Hz)]δCδH [m, J (Hz)]δC
27.67–7.738.76 s1528.50156-1348.5 s143
4--150-143-130-152
4a---------
5--121-140-128-120
6--156-157-134-157
87.67–7.738.58 s1408.42 (d, 5.28)1417.70 (d, 6.92)1297.97 s140
NH2-5.67 s-7.8 (NH)-5.32-5.44 s-
1′4.13–4.15
(q, 3.52, 5.56, Hz)
4.01–4.05 (t, J = 8.0 Hz)794.56–4.59 (t, 5.12, 10.68 Hz)60–734.11–4.14 (t, 9.88 Hz)60–73--
2′3.4–3.513.0–3.6 3.48–3.513.34–3.57--
3′73--
4′82--
5′62--
2′,3′-OH-----2.26---
2′,3′-OCOCH33.4–3.512.05 s174–177, 25.39–31.692.48–2.5920.29–21.56–
177
----
1″4.13–4.15
(q, 3.52, 5.56, Hz)
4.56–4.59 (t, 5.12 Hz, 10.68 Hz)60–734.11–4.14 (t, 3.8 Hz)60–73--
2″3.4–3.517.231163.41–3.513.34–3.57---
3″7.42120--
4″-156--
5″7.42120--
6″1.24–1.357.231161.2317.871.2314--
3″,4″,5″-OCH33.4–3.51--3.48–3.51703.51 s70--
1’’’3.4–3.513.6559.843.41–3.51663.34–3.57673.1749.15
2’’’1.62–1.632.88 s50.521.72–1.7320–302.0022–331.16–1.2831.18
3‴1.24–1.35-2061.21–1.241.2129
4‴2.11 s48.9925
5‴1.29 br.s25.13–32.026
6‴26
7‴2.4712.24–32.0
8‴1.16–1.28
9‴1.21–1.23 d1.76
10‴-20.820.8414.371.84
11‴--1.240.83 m
12‴1.62–1.63----0.83110.89 m
13‴0.86–0.90----2.47 s
14‴------2.36 d
15‴--- ---2.36 d
Table 2. Tentatively identified fatty acids in aerial parts of the petroleum ether extract A. canariense L.
Table 2. Tentatively identified fatty acids in aerial parts of the petroleum ether extract A. canariense L.
Retention TimeFatty AcidTypePercentage
20.8Pentadecanoic acid (C15:0)Saturated1.91%
21.12Cis-10-Pentadecenoic acid (C15:1)Unsaturated0.55%
23.936Heptadecanoic acid (margaric acid, C17)Saturated0.72%
37.24Cis-11-Eicosenoic acid (gondoic acid, C20:1)Unsaturated7.39%
43.20Docosanoic acid (Behenic acid, C22:0)Saturated28.30%
47.01Tricosanoic acid (Tricosylic acid, C23:0)Saturated43.08%
49.14Tetracosanoic (Lignoceric acid, C24:0) Saturated0.76%
52.03Nervonic acid (C24:1)Unsaturated8.94%
Saturated fatty acids 74.8%
Unsaturated fatty acids 16.9%
Table 3. Cytotoxic and anticholinestrase activities of the A. canariense L. extracts.
Table 3. Cytotoxic and anticholinestrase activities of the A. canariense L. extracts.
SampleAChE Inhibitory Effect
IC50 (ng/mL)
HCT-116
IC50 µg/mL
MCF-7
IC50 µg/mL
HepG-2
IC50 µg/mL
Alkaloid fraction183.43 ± 38.9814.40 ± 0.828.00 ± 1.221.00 ± 0.4
Aqueous alkaloid fraction139.27 ± 21.40
Methanolic extract112.24 ± 7.7321.20 ± 0.640.50 ± 3.126.40 ± 0.3
Dichloromethane62.48 ± 1.31
Tacrine27.29 ± 0.49
Doxorubicin 0.23 ± 0.170.42 ± 0.350.46 ± 0.2
Table 4. Mean inhibition zones in mm of alkaloidal and methanolic Aizoon canariense L. extracts.
Table 4. Mean inhibition zones in mm of alkaloidal and methanolic Aizoon canariense L. extracts.
Tested M.OAizoon canariense L. AlkaloidAizoon canariense L.
MeOH
Control
Fungi Ketoconazole
Aspergillus flavus (RCMB 002002)NA16 ± 1.5 ***16 ± 1.5 ***
Candida albicans (RCMB 005003, ATCC)16 ± 2 **12 ± 1.0 **20 ± 1.5 ***
Gram-Positive Bacteria  Gentamycin
Staphylococcus aureus (RCMB 010010)13 ± 1.5 **15 ± 1.0 **24 ± 2.0 ***
Bacillus subtilis (RCMB 015, NRRL B-543)14 ± 2 **13 ± 1.5 **26 ± 2 ***
Gram-Negative Bacteria  Gentamycin
Salmonella typhimurium (RCMB 006, ATCC 14028)15 ± 2.0 **13 ± 1.5 **17 ± 1.5 ***
Escherichia coli (RCMB 010052, ATCC25955)16 ± 1.5 ***18 ± 2.0 ***30 ± 2.0 ***
NA: No activity. Values are expressed as means of triplicate determination (n = 3) ± standard deviation. The statistical significance of the results was tested using one-way analysis of variance (ANOVA) and Tukey–Kramer multiple comparisons test. The p value significance was represented as an asterisk (**) for p < 0.01 and three asterisks (***) for p < 0.001.
Table 5. Minimum inhibitory concentration (MIC) values in μg/mL for alkaloid and methanolic Aizoon canariense L. extracts.
Table 5. Minimum inhibitory concentration (MIC) values in μg/mL for alkaloid and methanolic Aizoon canariense L. extracts.
Tested Micro-OrganismTested Extract
A. canariense L. AlkaloidA. canariense L. MeOHStandard
FUNGI  Amphotericin B
Aspergillus flavus (RCMB 002002)NA12500.98
Candida albicans (RCMB 005003, ATCC)62525000.49
Gram-Positive Bacteria  Ampicillin
Staphylococcus aureus (RCMB 010010)12506250.49
Bacillus subtilis (RCMB 015, NRRL B-543)25006250.49
Gram-Negative Bacteria  Gentamicin
Salmonella typhimurium (RCMB 006, ATCC 14028)125025000.98
Escherichia coli (RCMB 010052, ATCC25955)312.56223.9
NA: No activity.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Bakr, R.O.; El-Behairy, M.F.; Elissawy, A.M.; Elimam, H.; Fayed, M.A.A. New Adenosine Derivatives from Aizoon canariense L.: In Vitro Anticholinesterase, Antimicrobial, and Cytotoxic Evaluation of Its Extracts. Molecules 2021, 26, 1198. https://doi.org/10.3390/molecules26051198

AMA Style

Bakr RO, El-Behairy MF, Elissawy AM, Elimam H, Fayed MAA. New Adenosine Derivatives from Aizoon canariense L.: In Vitro Anticholinesterase, Antimicrobial, and Cytotoxic Evaluation of Its Extracts. Molecules. 2021; 26(5):1198. https://doi.org/10.3390/molecules26051198

Chicago/Turabian Style

Bakr, Riham O., Mohammed F. El-Behairy, Ahmed M. Elissawy, Hanan Elimam, and Marwa A. A. Fayed. 2021. "New Adenosine Derivatives from Aizoon canariense L.: In Vitro Anticholinesterase, Antimicrobial, and Cytotoxic Evaluation of Its Extracts" Molecules 26, no. 5: 1198. https://doi.org/10.3390/molecules26051198

Article Metrics

Back to TopTop